Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss
Clinical Obesity · 2026
DOI: 10.1111/cob.70037 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Obesity, 2026. Verfasst von John M Jakicic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Physical Activity and Weight Management, Department of Internal Medicine, University of Kansas Medical Center, Kansas, USA. Hauptthemen laut MEDLINE: Weight Loss, Hydrogels, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Epitomee Medical Ltd.
Abstract (Originalsprache)
Early response (ER) to treatment is predictive of longer‐term weight loss. In this post hoc analysis, ER to an oral shape‐shifting superabsorbent hydrogel capsule (Epitomee) combined with a lifestyle intervention was compared to placebo combined with a lifestyle intervention. Participants (age = 48.5 ± 12.5 and 48.6 ± 12.4; BMI = 34.1 ± 3.3 and 33.7 ± 3.4, in the Epitomee and placebo groups, respectively) were randomised to Epitomee ( N = 138) or placebo ( N = 141) with lifestyle intervention. Analyses included body weight measurements taken at baseline, week 8, and week 24. Of the 279 participants enrolled in the study, 250 (90% of the ITT population) provided weight data, including 124 participants in the Epitomee group and 126 in the placebo group. Participants with missing weight data at week 24 were classified as non‐responders. Early response (ER) was defined as a weight loss of ≥ 2% at week 8. Weight loss at week 24 was greater in ER to Epitomee compared to placebo (9.3% ± 6.0% vs. 6.9% ± 4.3%; p < 0.0001). The odds ratio for ER to achieve > 5% weight loss at week 24 was 4.10 (95% CI: 1.02, 16.46) for Epitomee and 2.38 (95% CI: 0.62, 9.21) for placebo. A greater proportion of ER to Epitomee, compared to placebo, achieved > 5% (76% vs. 62%; p = 0.0472), ≥ 7% (61% vs. 38%; p < 0.0045) and ≥ 10% (39% vs. 17%; p < 0.0025) weight loss at week 24. ER response to Epitomee was associated with greater weight loss at 24 weeks compared to placebo. Monitoring ER to Epitomee and titrating treatment based on ER may enhance weight loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Physical Activity and Weight Management, Department of Internal Medicine, University of Kansas Medical Center, Kansas, USA.
- Pennington Biomedical Research Center, Louisiana State University, Louisiana, USA.
- Department of Epidemiology and Prevention and Department of Medicine, Wake Forest University School of Medicine, North Carolina, USA.
- Weight Management Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Medicine, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Nutrition Sciences, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: John M Jakicic, Patrick M O'Neil, Eti Ganon-Elazar
Förderung
- NIDDK NIH HHS
- Epitomee Medical Ltd
Zitieren
APA
Jakicic, J. M., Ryan, D. H., Ard, J. D., O'Neil, P. M., Kushner, R. F., Wyatt, H. R., Bays, H. E., Greenway, F. L., Leonard, S., Kenan, Y., Ganon-Elazar, E., & Wadden, T. A. (2026). Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss. Clinical Obesity. https://doi.org/10.1111/cob.70037
Vancouver
Jakicic JM, Ryan DH, Ard JD, O'Neil PM, Kushner RF, Wyatt HR, et al. Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss. Clinical Obesity. 2026. doi:10.1111/cob.70037
BibTeX
@article{Jakicic2026,
author = {Jakicic, John M and Ryan, Donna H and Ard, Jamy D and O'Neil, Patrick M and Kushner, Robert F and Wyatt, Holly R and Bays, Harold E and Greenway, Frank L and Leonard, Sharon and Kenan, Yael and Ganon-Elazar, Eti and Wadden, Thomas A},
title = {Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss},
journal = {Clinical Obesity},
year = {2026},
doi = {10.1111/cob.70037}
}
EUVIMED